 | Rigel Pharmaceuticals Provides Business Update Prior to Investor & Analyst Call
finance.yahoo.com - October 23 at 8:32 AM |
| If You Had Bought Rigel Pharmaceuticals (NASDAQ:RIGL) Stock A Year Ago, You'd Be Sitting On A 42% Loss, Today
finance.yahoo.com - October 22 at 5:56 PM |
| If You Had Bought Rigel Pharmaceuticals (NASDAQ:RIGL) Stock A Year Ago, You'd Be Sitting On A 42% Loss, Today
finance.yahoo.com - October 22 at 5:56 PM |
 | Cantor Fitzgerald Reiterates "Overweight" Rating for Rigel Pharmaceuticals (NASDAQ:RIGL)
www.americanbankingnews.com - October 22 at 7:54 AM |
| Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - October 21 at 9:50 AM |
 | Rigel Pharma not quite there with European application for fostamatinib
seekingalpha.com - October 18 at 9:46 AM |
| Rigel Receives Positive Trend Vote from CHMP for Fostamatinib Disodium Hexahydrate for Adult Patients with Chronic Immune Thrombocytopenia (ITP) in Europe
finance.yahoo.com - October 18 at 9:46 AM |
| Rigel to Host Investor and Analyst Call on October 23, 2019
finance.yahoo.com - October 16 at 7:51 AM |
| Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Sees Large Decline in Short Interest
www.americanbankingnews.com - October 15 at 6:33 PM |
| Rigel Makes Progress, But Doesn't Make A Big Deal About It
seekingalpha.com - October 15 at 8:59 AM |
| Analysts Anticipate Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Will Announce Quarterly Sales of $12.04 Million
www.americanbankingnews.com - October 15 at 4:54 AM |
| Aclaris Divests Rhofade to EPI Health for $55M, Shares Up
finance.yahoo.com - October 14 at 12:20 PM |
| Analysts Anticipate Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Will Post Earnings of -$0.13 Per Share
www.americanbankingnews.com - October 13 at 7:48 AM |
| Rigel Secures Credit Facility for Up to $60 Million
finance.yahoo.com - October 2 at 5:18 PM |
| Kissei Pharma launches late-stage study of fostamatinib for ITP in Japan
seekingalpha.com - September 23 at 3:46 PM |
| Rigel's fostamatinib Enters Phase 3 Clinical Trial in Japan with Kissei Pharmaceuticals for the Treatment of Chronic Immune Thrombocytopenia
finance.yahoo.com - September 23 at 7:44 AM |
| Should You Be Concerned About Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) Historical Volatility?
finance.yahoo.com - September 22 at 6:40 AM |
| Rigel's CEO to Participate in Panel Discussion at Citi's 14th Annual Biotech Conference
finance.yahoo.com - August 28 at 8:51 AM |
| Who Has Been Buying Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Shares?
finance.yahoo.com - August 16 at 6:49 PM |
| Rigel's Q2 Earnings Beat Provides Confidence In Commercial Strategy
seekingalpha.com - August 9 at 6:57 PM |
| Edited Transcript of RIGL earnings conference call or presentation 6-Aug-19 8:30pm GMT
finance.yahoo.com - August 7 at 5:48 PM |
| Rigel Pharmaceuticals Inc (RIGL) Q2 2019 Earnings Call Transcript
finance.yahoo.com - August 6 at 11:44 PM |
| Rigel Pharmaceuticals EPS beats by $0.02, beats on revenue
seekingalpha.com - August 6 at 6:44 PM |
| Rigel Announces Second Quarter 2019 Financial Results and Provides Business Update
finance.yahoo.com - August 6 at 6:44 PM |
| Rigel Announces Conference Call and Webcast to Report Second Quarter 2019 Financial Results
finance.yahoo.com - July 30 at 8:45 AM |
| Rigel: Competitors And Collaborators
seekingalpha.com - July 19 at 5:00 PM |
| Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL): Are Analysts Optimistic?
finance.yahoo.com - July 9 at 9:37 AM |
| Here’s What Hedge Funds Think About Rigel Pharmaceuticals, Inc. (RIGL)
finance.yahoo.com - June 24 at 5:21 PM |
| Rigel to Present Two Posters Highlighting Fostamatinib at the 24ᵗʰ Congress of the European Hematology Association (EHA)
finance.yahoo.com - June 13 at 12:51 PM |
| Rigel Pharmaceuticals Sees Hammer Chart Pattern: Time to Buy?
finance.yahoo.com - June 5 at 9:18 AM |
| Rigel to Present at Jefferies 2019 Healthcare Conference
finance.yahoo.com - May 31 at 9:29 AM |
 | Rigel Pharmaceuticals Inc.
www.barrons.com - May 24 at 6:05 PM |
| Rigel begins patient enrollment in late-stage AHIA study
seekingalpha.com - May 16 at 10:58 AM |
| Rigel Enrolls First Patient in Phase 3 Clinical Trial of Fostamatinib Disodium Hexahydrate in Warm Autoimmune Hemolytic Anemia
finance.yahoo.com - May 16 at 10:58 AM |
| Rigel Reports An Earnings Beat, But The Market Shrugs It Off
seekingalpha.com - May 11 at 9:36 AM |
| Rigel Pharmaceuticals, Inc. 2019 Q1 - Results - Earnings Call Slides
seekingalpha.com - May 8 at 6:42 PM |
 | Rigel Pharmaceuticals (RIGL) Reports Q1 Loss, Tops Revenue Estimates
www.nasdaq.com - May 8 at 9:26 AM |
| Edited Transcript of RIGL earnings conference call or presentation 7-May-19 8:30pm GMT
finance.yahoo.com - May 8 at 9:26 AM |
 | Rigel Pharmaceuticals Inc (RIGL) Q1 2019 Earnings Call Transcript
www.fool.com - May 8 at 2:10 AM |
 | BerGenBio ASA: Results for the First Quarter 2019
www.prnewswire.com - May 8 at 1:17 AM |
| Rigel Pharmaceuticals beats by $0.02, beats on revenue
seekingalpha.com - May 7 at 6:06 PM |
| Rigel Announces First Quarter 2019 Financial Results and Provides Company Update
www.prnewswire.com - May 7 at 6:06 PM |
| Rigel Announces Conference Call and Webcast to Report First Quarter 2019 Financial Results and Company Update
finance.yahoo.com - April 30 at 9:21 AM |
| If You Had Bought Rigel Pharmaceuticals (NASDAQ:RIGL) Stock A Year Ago, You'd Be Sitting On A 40% Loss, Today
finance.yahoo.com - April 18 at 9:41 AM |
| Here's Why Rigel Pharmaceuticals Gained 17.3% in March
finance.yahoo.com - April 10 at 11:24 AM |
| Here's Why Rigel Pharmaceuticals Gained 17.3% in March
www.fool.com - April 9 at 8:58 PM |
| Rigel Welcomes Jane Wasman to Board of Directors
finance.yahoo.com - March 26 at 9:39 AM |
 | Rigel Pharmaceuticals Inc
www.bloomberg.com - March 19 at 9:47 AM |
| Is Rigel Pharmaceuticals, Inc.’s (NASDAQ:RIGL) CEO Overpaid Relative To Its Peers?
finance.yahoo.com - March 12 at 5:59 PM |
| Edited Transcript of RIGL earnings conference call or presentation 28-Feb-19 10:00pm GMT
finance.yahoo.com - March 4 at 6:35 PM |
